Jesper Filtenborg Tvedskov

Copenhagen University Hospital

Papers

3

Total Citations

12

H-Index

3

About

Jesper Filtenborg Tvedskov is a leading head and neck surgeon whose work centers on advancing transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of HPV-induced disease. His major contributions include pioneering the use of patient-centered outcome metrics, such as "days alive and out of hospital" (DAOH), to quantify postoperative morbidity in a landmark cohort study of 262 patients—a novel approach that captures both survival and recovery quality. He has also driven innovation in intraoperative tumor margin assessment, demonstrating the feasibility of 3D ultrasound to reduce the need for additional radiotherapy after TORS. His 2018 review on TORS for head and neck cancer remains a key reference for clinicians navigating the shift toward minimally invasive treatment for younger, HPV-positive patients with favorable prognoses. With over 12 citations across his most impactful works, Tvedskov’s research is shaping how surgeons balance oncologic efficacy with functional preservation, offering tangible improvements in patient recovery and long-term outcomes.

Research Focus

Key Achievements

3
H-Index
3
Papers
12
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer
6 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Copenhagen University Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago